Pharmacogenomics in Rare Diseases: Development Strategy for Ivacaftor...
...as a Therapy for Cystic Fibrosis Session 1: Pharmacogenomics: regulatory and methodological implications in early clinical development Speaker: Federico Goodsaid, Vertex Pharmaceuticals, USA Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:1 0ratingsTime:32:26More inScience Technology
See the original post:
Pharmacogenomics in Rare Diseases: Development Strategy for Ivacaftor... - Video
Recommendation and review posted by G. Smith
